Drug Search Results
More Filters [+]


Alternative Names: xantocillin
Latest Update: 2023-09-25
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: ERK Inhibitor,MAP2K Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Xantocillin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases



Trial Status


Primary Completion Date

Probability of Success

Recent News Events